Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil MacRitchie

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Pharmacology & Therapeutics|October 13, 2012
Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?Gianluca Grassia, Neil MacRitchie, Andrew M Platt, et al.
Frontiers in Immunology|May 10, 2019
A Novel Triple-Cell Two-Dimensional Model to Study Immune-Vascular Interplay in AtherosclerosisJonathan Noonan, Gianluca Grassia, Neil MacRitchie, et al.
Seminars in Immunology|December 4, 2021
Nanoparticle theranostics in cardiovascular inflammationNeil MacRitchie, Valentina Di Francesco, Miguel Filipe Moreira Marques Ferreira, et al.
Cardiovascular Research|October 26, 2021
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspectiveEleanor C Murray, Ryszard Nosalski, Neil MacRitchie, et al.
British Journal of Pharmacology|November 20, 2016
Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitisMark Barbour, Melissa McNaughton, Stephanie D Boomkamp, et al.
Pharmacological Research|August 23, 2025
Selective EPAC1 Activators Enhance Endothelial Function in Models of Vascular InflammationNeil MacRitchie, Danila Gurgone, Jolanta Wiejak, et al.
Biomed Research International|August 20, 2014
Murine aortic smooth muscle cells acquire, though fail to present exogenous protein antigens on major histocompatibility complex class II moleculesMarcella Maddaluno, Neil MacRitchie, Gianluca Grassia, et al.
Journal of Medicinal Chemistry|October 30, 2013
Structure-activity relationships and molecular modeling of sphingosine kinase inhibitorsDong Jae Baek, Neil MacRitchie, Nahoum G Anthony, et al.
Cellular Signalling|April 12, 2016
Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertensionNeil MacRitchie, Giora Volpert, Mohammed Al Washih, et al.
Analytical Chemistry|April 9, 2026
Correction to "Detection of Inflammation in Vivo by Surface-Enhanced Raman Scattering Provides Higher Sensitivity Than Conventional Fluorescence Imaging"Ross McQueenie, Ross Stevenson, Robert Benson, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Pharmacology & Therapeutics|October 13, 2012
Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?Gianluca Grassia, Neil MacRitchie, Andrew M Platt, et al.
Frontiers in Immunology|May 10, 2019
A Novel Triple-Cell Two-Dimensional Model to Study Immune-Vascular Interplay in AtherosclerosisJonathan Noonan, Gianluca Grassia, Neil MacRitchie, et al.
Seminars in Immunology|December 4, 2021
Nanoparticle theranostics in cardiovascular inflammationNeil MacRitchie, Valentina Di Francesco, Miguel Filipe Moreira Marques Ferreira, et al.
Cardiovascular Research|October 26, 2021
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspectiveEleanor C Murray, Ryszard Nosalski, Neil MacRitchie, et al.
British Journal of Pharmacology|November 20, 2016
Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitisMark Barbour, Melissa McNaughton, Stephanie D Boomkamp, et al.
Pharmacological Research|August 23, 2025
Selective EPAC1 Activators Enhance Endothelial Function in Models of Vascular InflammationNeil MacRitchie, Danila Gurgone, Jolanta Wiejak, et al.
Biomed Research International|August 20, 2014
Murine aortic smooth muscle cells acquire, though fail to present exogenous protein antigens on major histocompatibility complex class II moleculesMarcella Maddaluno, Neil MacRitchie, Gianluca Grassia, et al.
Journal of Medicinal Chemistry|October 30, 2013
Structure-activity relationships and molecular modeling of sphingosine kinase inhibitorsDong Jae Baek, Neil MacRitchie, Nahoum G Anthony, et al.
Cellular Signalling|April 12, 2016
Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertensionNeil MacRitchie, Giora Volpert, Mohammed Al Washih, et al.
Analytical Chemistry|April 9, 2026
Correction to "Detection of Inflammation in Vivo by Surface-Enhanced Raman Scattering Provides Higher Sensitivity Than Conventional Fluorescence Imaging"Ross McQueenie, Ross Stevenson, Robert Benson, et al.
Pageof 3